*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C751 - Malignant neoplasm of pituitary gland - as a primary diagnosis code | C751 - Malignant neoplasm of pituitary gland - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 8.69 | |
| Readmission Rate (%) | 29.44 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 614: ADRENAL AND PITUITARY PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|
| Total Hospitalizations at DRG | 5,549 | |
| Total Hospitalizations with ICD C751 - Malignant neoplasm of pituitary gland | 17 | |
| DRG Share of Total Hospitalizations | 0.02 | |
| % of Total ICD C751 - Malignant neoplasm of pituitary gland in DRG | 36.17 | |
| Avg LOS at DRG | 4.81 | |
| Avg LOS with ICD C751 - Malignant neoplasm of pituitary gland | 7.47 | |
| Readmission Rate at DRG | 15.7 | |
| Readmission Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |
| Unplanned Readmission Rate at DRG | 8.49 | |
| Unplanned Readmission Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |
| Total Medicare payments at DRG | $99,799,011 | |
| Total Medicare payments with ICD C751 - Malignant neoplasm of pituitary gland | $413,469 | |
| Total Medicare payment per Day at DRG | $3,740 | |
| Total Medicare payment per Day with ICD C751 - Malignant neoplasm of pituitary gland | $3,256 | |
| Total Medicare payment per Hospitalization at DRG | $17,985 | |
| Total Medicare payment per Hospitalization with ICD C751 - Malignant neoplasm of pituitary gland | $24,322 | |
| Total Medicare Charges at DRG | $522,536,699 | |
| Total Medicare Charges with ICD C751 - Malignant neoplasm of pituitary gland | $3,081,600 | |
| Avg Charges at DRG | $94,168 | |
| Avg Charges with ICD C751 - Malignant neoplasm of pituitary gland | $181,271 | |
| Mortality Rate at DRG | 1.06 | |
| Mortality Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |
| SNF Discharge Rate at DRG | 5.46 | |
| SNF Discharge Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |
| Home Discharge Rate at DRG | 76.79 | |
| Home Discharge Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 614: ADRENAL AND PITUITARY PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,549 | |||
| Total Hospitalizations with ICD C751 - Malignant neoplasm of pituitary gland | 19 | |||
| DRG Share of Total Hospitalizations | 0.02 | |||
| % of Total ICD C751 - Malignant neoplasm of pituitary gland in DRG | 8.76 | |||
| Avg LOS at DRG | 4.81 | |||
| Avg LOS with ICD C751 - Malignant neoplasm of pituitary gland | 6.95 | |||
| Readmission Rate at DRG | 15.7 | |||
| Readmission Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |||
| Unplanned Readmission Rate at DRG | 8.49 | |||
| Unplanned Readmission Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |||
| Total Medicare payments at DRG | $99,799,011 | |||
| Total Medicare payments with ICD C751 - Malignant neoplasm of pituitary gland | $443,158 | |||
| Total Medicare payment per Day at DRG | $3,740 | |||
| Total Medicare payment per Day with ICD C751 - Malignant neoplasm of pituitary gland | $3,357 | |||
| Total Medicare payment per Hospitalization at DRG | $17,985 | |||
| Total Medicare payment per Hospitalization with ICD C751 - Malignant neoplasm of pituitary gland | $23,324 | |||
| Total Medicare Charges at DRG | $522,536,699 | |||
| Total Medicare Charges with ICD C751 - Malignant neoplasm of pituitary gland | $3,255,270 | |||
| Avg Charges at DRG | $94,168 | |||
| Avg Charges with ICD C751 - Malignant neoplasm of pituitary gland | $171,330 | |||
| Mortality Rate at DRG | 1.06 | |||
| Mortality Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |||
| SNF Discharge Rate at DRG | 5.46 | |||
| SNF Discharge Rate with ICD C751 - Malignant neoplasm of pituitary gland | NA | |||
| Home Discharge Rate at DRG | 76.79 | |||
| Home Discharge Rate with ICD C751 - Malignant neoplasm of pituitary gland | 63.16 |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | E230 | Hypopituitarism |
| 2 | E039 | Hypothyroidism, unspecified |